More MS news articles for February 2003

Abbott Working On More Monoclonal Antibodies, Histamine And Nicotinic Drugs

http://www.biospace.com/news_story.cfm?StoryID=11732720&full=1

Feb 18, 2003
Reuters Health
London

Abbott Laboratories on Monday said clinical trials of J695, a human monoclonal antibody that neutralises interleukin-12, are about to start in multiple sclerosis in addition to the previously announced trials in rheumatoid arthritis and Crohn's disease.